OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Lip Pain reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,828 reports · 52 co-occurring drugs

As of the last recalculation, Lip Pain appears in 2,828 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is GLYCERIN, LIDOCAINE (PRR 80.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Glycerin, Lidocaine14680.981.7
Docosanol15180.080.9
Quinine108.68.6
Cabozantinib507.87.8
Lapatinib157.17.2
Acetylcysteine97.07.1
Ketoconazole Foam147.07.0
Ketoconazole Cream, 2%147.07.0
Ketoconazole156.46.4
Niraparib186.06.0
Drs. Clotrimazole95.75.7
Family Wellness Clotrimazole95.75.7
Clotrimazole Topical95.75.7
Losartan Potassium And Hydrochlorothiazide95.75.7
Nicotine Polacrilex Mini115.45.4
Nicotine Polarilex115.45.4
Regorafenib85.15.1
Dexamethasone Sodium Phosphate75.15.1
Voriconazole Injection134.44.4
Sunitinib Malate234.34.3
Alpelisib54.24.2
Voriconazole174.14.1
Nicotine Polacrilex214.14.1
Irinotecan Hydrochloride74.04.0
Palbociclib493.83.8
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate213.83.8
Fluticasone Propionate And Salmeterol213.73.7
Timolol63.73.7
Botulinum Toxin Type A63.63.6
Armodafinil103.53.5
Capecitabine413.33.3
Cetuximab143.33.3
Nicotine173.13.1
Crisaborole43.13.1
Isotretinoin192.82.8
Axitinib72.62.6
Peginterferon Alfa-2A192.62.6
Avapritinib42.42.4
Nirmatrelvir And Ritonavir172.32.3
Onabotulinumtoxina242.32.3
Sarilumab82.22.2
Budesonide, Glycopyrrolate, And Formoterol Fumarate32.12.1
Ixazomib82.02.0
Lenvatinib92.02.0
Orlistat72.02.0
Fremanezumab-Vfrm31.91.9
Cenegermin-Bkbj31.81.8
Lifitegrast41.81.8
Pirfenidone91.61.6
Ixekizumab81.61.6
Dupilumab971.51.5
Adapalene80.30.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.